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Abstract	
	
Purple	yam	(Dioscorea	alata	L.)	is	a	source	of	biological	tubers	not	been	used	optimally.	
Diosgenin	is	steroids	saponin	compounds	that	most	important	because	it	has	multiple	biological	
functions,	such	as	allergenic	activity.	The	objective	of	this	research		was	to	analyze	the	potential	
allergenic	ethanol	extract	tuber	of	D.	alata	L.	(EEDA)	on	BALB/c	mice	on	sensitivity	phase	with	
measure	the	profile	of	transcription	factor	FoxP3	Treg	cells	and	cytokine	profile	of	Treg	and	IgE	
and	IgG1	B	cells.	An	experimental	study	using	BALB/c		mice	divided	into	7	groups:	control	group	
(I),	the	treatment	group	(II‐V)	ethanol	extract	of	tuber	Dioscorea	alata	L.	dose	of	0.00;	0.17;	2.01;	
10.04	 g/kg	 bw,	 the	 treatment	 group	 antihistamines	 drug	 and	 Diosgenin	 (VI‐VII).	 For	 17	
consecutive	days	the	group	II‐VII	were	treated	in	accordance	with	the	group	and	with	Ovalbumin	
induced	allergy	models.	Mice	were	sacrificed	on	day	18.	Spleen	is	removed,	lymphocyte	isolated		
and	analyze	the	transcription	factor	FoxP3	Treg	cells,	cytokine	profile	of	T	reg	cells		and	IgE	and	
IgG1	 B	 cells	 on	 spleen	 using	 Flowcytometry	 FACS	 Calibur.	 The	 results	 showed	 EEDA	 able	 to	
inhibit	 the	 production	 of	 B220IgE	 and	 B220IgG1,	 	 trigger	 Treg	 cells	 (CD4CD25)	 and	 the	
transcription	factor	FoxP3	(CD4CD25FoxP3)	and	profile	of	the	cytokines	produced	by	T	reg	cells.	
The	 conclusion	 is	 ethanol	 extract	 tubers	 of	 Dioscorea	 alata	 L	 (EEDA)	 does	 not	 trigger	 Treg	
(CD4CD25)	and	the	transcription	factor	FoxP3	(CD4CD25FoxP3)	and	cytokine	profiles	produced	
by	Treg	cells	namely	CD4IL‐10,	CD8IL‐10,	CD4TGF‐β	and	CD8TGF	‐β	in	the	sensitivity	phase.	
	
Keywords:	Saponin	steroid	of	ethanol	extract	of	the	tubers	of	Dioscorea	alata	L.;	allergenic	agent;	
Treg	cells;	the	transcription	factor	FoxP3;	lymphocyte.	
	
	
1. Introduction	
	
Purple	yam	(Dioscorea	alata	L.)	is	a	source	of	biological	tubers	that	has	not	been	
used	 optimally.	 D.	alata	L.	contains	 Diosgenin	 (Cheng	 et	al.,	 2007)	 i.e.	 main	 steroidal	
saponin	 steroid	 aglicon	 as	 intermediate	 steroidal	 in	 pharmaceutical	 manufacture.	
Steroidal	saponin	is	the	most	importance	bioactive	compound	because	it	have	biological	
function.	 The	 result	 of	 some	 research	 showed	 that	 steroidal	 saponin	 have	 allergenic	
activity		(Zhang	et	al.,	2012).		
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The	latest	studies	of	T	regulatory	(Treg)	cells	reveals	the	importance	of	effector	
function	of	this	cell	population	in	controlling	allergic	responses.	It	has	been	proven	that	
an	 allergic	 person	 reduce	 the	 number	 and	 function	 of	 Treg	 (Shreffler	 et	 al.,	 2009;	
Palomares	 et	 al.,	 2010).	 Treg	 cells	 is	 able	 to	 inhibit	 the	 development	 of	 allergic	 Th2	
response	 (Akdis	 et	 al.,	 2004)	 and	 plays	 an	 important	 role	 in	 allergen	 specific	
immunotherapy	(Akdis	et	al.,	1998;	Jutel	et	al.,	2003).	FoxP3	transcription	 factor	plays	
an	important	role	in	the	maintaining	self‐tolerance	and	immune	homeostasis	(Sakaguchi	
et	al.,	2008).	FoxP3	transcription	factor	important	in	the	development	of	Treg	cells	and	a	
marker	of	 confirming	 the	presence	of	Treg	cells	 (Zheng	&	Rudensky,	2007;	 Sakaguchi,	
2004).	
Treg	cells	produce	IL‐10	and	TGF‐	cytokines	which		they	inhibit	the	activation	
of	 lymphocytes	 and	macrophages.	 Treg	 cells	 also	 directly	 interact	 and	 suppress	 other	
lymphocytes	or	antigen	presenting	cells	(Abbas	&	Lichtman,	2011).	Treg	 	cells	through	
its	 cytokines,	 	 IL‐10	 and	 TGF‐β,	 capable	 monitoring	 the	 immune	 response,	 inhibits	
hyperpolarization	 Th1	 (autoimmune	 disease)	 or	 Th2	 (allergic	 diseases)	 and	 further	
regulate	 the	 balance	 of	 Th1/Th2	 (Gourbeyre	 et	 al.,	 2011)	 as	 well	 as	 suppressing	 IgE	
released	by	B	cells	(Huang	et	al.,	2009).	TGF‐	is	an	important	factor	in	the	regulation	of	
T	cell	mediated	immune	response	and	plays	a	role	in	the	induction	of	immune	tolerance	
(Gorelik	and	Flavell,	2002;	Chen	&	Wahl,	2002).	
Allergic	 reactions	 involving	 IgE	 specific	 antibodies	 (Ewan,	 1998).	 IgE	 is	 a	 key	
molecules	 that	 act	 as	mediators	 of	 allergic	 responses	 (asthma,	 rhinitis,	 food	 allergies,	
atopic	 dermatitis,	 etc.)	 (Gould	 &	 Sutton,	 2008).	 According	 to	 Saldanha	 et	 al.	 (2004),	
Ovalbumin	 as	 allergen	 sensitization	 in	mice	 increases	 levels	 of	 IgE	 and	 IgG1	 in	 blood	
sera.	
The	 objective	 of	 this	 research	 	was	 to	 analyze	 the	 potential	 allergenic	 ethanol	
extract	 tuber	 of	 Dioscorea	 alata	 L.	 (EEDA)	 on	 BALB/c	mice	 on	 sensitivity	 phase	with	
measure	the	profile	of	the	transcription	factor	FoxP3	Treg	cells	and	cytokine	profile	of	
Treg	and	IgE	and	IgG1	B	cells.		
	
2. Materials	and	Methods	
	
Experimental	animals	are	mice	(Mus	musculus)	BALB/c	strain,	7‐8	weeks	with	a	
healthy	 condition.	 This	 research	 has	 got	 the	 certificate	 of	 eligibility	 of	 ethics	 (Ethical	
Clearance)	of	the	Research	Ethics	Committee	(Animal	Care	and	Use	Committee)	UB	No.	
KEP‐144‐UB.	
Experimental	 research	on	BALB/c	mice	with	posttest	only	control	group	design.	
Independent	variable	is	ethanol	extract	of	tubers	Dioscorea	alata	L.	dose	0.00	g/kg,	0.17	
g/kg,	 2.01	 g/kg	 and	 10.04	 g/kg.	 Dependent	 variable	 is	 profile	 of	 transcription	 factor	
FoxP3,	cytokine	profile	of	T	reg	cells	(IL‐10,	TGF‐β)	and	IgE	and	IgG1	B	cells	on	spleen.	
Dose	 ethanol	 extract	 of	 the	 tubers	 of	 Dioscorea	 alata	 L.	 converted	 from	 dose	
human	weighing	70	kg	to	20	grams	mice,	multiplied	by	the	conversion	value	0.0026,	so	
we	get	first	dose	of	0.17	g/kg,	2	doses	of	2.01	g/kg	and	3	doses	of	10.04	g	/	kg.		
Mice	 Model	 Allergic	 Digestive	 Tract	 on	 Sensitivity	 Phase.	 BALB/c	 mice	
intraperitoneally	 sensitized	 with	 Ovalbumin.	 Mice	 immunized	 with	 intraperitoneal	
injections	 on	 day	 15	 with	 0.15	 ml	 Ovalbumin	 in	 Al(OH)3	which	 is	 made	 of	 2.5	 mg	
Ovalbumin	dissolved	in	7.75	ml	of	Alumunium	Hydroxide	(Fischer	et	al.,	2005;	Diding	et	
al.,	2008).		
Twenty	one	male	Balb	C	mice	divided	into	seven	groups:	control	(C),	treatments	
with	 ethanol	 extract	 tubers	 of	 Dioscorea	 alata	 0,00	 g/kg,	 0.17	 g/kg,	 2.01	 g/kg,	 10.04	
g/kg	 (T	 I	 –	 T	 IV),	 treatment	 with	 antihistamine	 drug	 0,4	 mg/mice/day	 (T	 V)	 	 and	
treatment	 	with	Diosgenin	200	mg/kg	 	 (T	VI)	 (Huang	et	al.,	2010).	For	17	consecutive	
days	the	T	I‐	T	IV	groups	were	given	ethanol	extract	of	D.	alata	respectively	with	its	dose,	
T	IV	group	given	antihistamine	drugs		and	T	V	group	given	Diosgenin.	On	day	15,	NC	dan	
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T	I	–	T	V	groups	of	mice	were	induced	Ovalbumin	0,0483	mg/mice	(Fischer	et	al.,	2005		
with	 modification	 by	 Diding	 et	 al.,	 2008).	 On	 day	 18,	 three	 mice	 each	 group	 were	
sacrificed	with	cervical	dislocation,	mice	were	dissected	and	spleen	is	taken	to	isolated	
its	lymphocytes	and	analyze	the	transcription	factor	FoxP3	Treg	cells,	cytokine	profile	of	
T	reg	cells	and	IgE	and	IgG1	B	cells	on	spleen	using	Flowcytometry	FACS	Calibur.		
Statistical	analysis	of	the	data.	Data	are	presented	as	means	±	SD.	Comparison	
between	 groups	 was	 performed	 by	 the	 one‐way	 analysis	 of	 variance	 continued	 with	
Tukey	test.	Considered	a	value	of	p	<0.05	was	statistically	significant.	
	
3. Results	and	Discussion	
	
Body	 weight	 of	 mice	 on	 sensitization	 phase	 weighed	 every	 day	 for	 17	
consecutive	 days.	 Figure	 1	 showed	 the	 weight	 of	 mice	 on	 sensitization	 phase	 after	
injected	Ovalbumin	intraperitoneally	on	day	15	experienced	a	weight	loss	of	5.44%	on	
the	16th	day	and	4.15%	on	day	17.	There	is	significant	effect	of	Ovalbumin	injection	on	
weight	loss	(p	<0.05).	
Weight	parameter	in	this	study	need	to	be	displayed	because	one	of	the	marker	
of	success	murine	model	of	allergic	is	the	occurrence	of	diarrhea	in	mice	is	characterized	
by	watery	stools	and	weight	loss.	This	study	succeeded	in	making	mice	model	of	allergic	
through	a	slight	drop	weight	after	giving	Ovalbumin	allergen	which	is	appropriate	with		
Mollica	et	al.	(2013)	research.	The	diarrhea	in	mice	is	characterized	by	watery	stool	that	
also	 occurs	 in	mice	model	 of	 allergic	 gastrointestinal	 tract	 is	 shown	with	 stools	more	
watery	and	runny.	
This	research	indicate	that	there	is	no	difference	in	feed	intake	between	groups	
of	mice,	but	mice	treated	Ovalbumin	lose	a	little	of	their	body	weight.	It	is	caused	by	the	
occurrence	 of	 hypercatabolism	 which	 are	 caused	 by	 the	 production	 of	 inflammatory	
cytokines	(Dourado	et	al.,	2010).	This	study	did	not	evaluate	further	whether	weight	loss	
in	 the	 treatment	 group	 Ova	 is	 caused	 by	 a	 decrease	 in	 feed	 consumption	 or	 water	
retention	as	Moreira	(2006)	research	in	mice	were	sensitized	with	Ovalbumin.	Jan	et	al.	
(2007)	 research	also	showed	 that	 the	body	weight	of	mice	which	 is	 treated	Diosgenin	
dose	 200	 and	 400	mg/kg,	 there	was	 no	 significant	 difference	 in	 body	weight	 of	mice	
untreated	control	group.	
	
	
Figure	1.	Comparison	of	body	weight	of	mice	(g)	on	the	sensitivity	phase	in	the	control	group	(C)	and	treatment	group	
with	EEDA	0.00;	0.17;	2.01	and	EEDA	10.04	g/kg,	Antihistamines	Drugs	and	Diosgenin.		
	
According	to	Saldanha	et	al.	(2004),	Ovalbumin	as	allergen	sensitization	in	mice	
increases	levels	of	IgE	and	IgG1	in	blood	sera.	IgE	and	IgG1	(Th2	response)	versus	IgG2a	
(Th1	response)	 is	a	good	marker	for	 the	 induction	of	allergic	responses	in	mice	(Adel‐
Patient	 et	 al.,	 2000).	 According	 Dourado	 et	 al.	 (2011),	 sensitization	 Ovalbumin	 in	
BALB/c	mice	increases	levels	of	IgE	and	IgG1.	
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This	 study	 showed	 that	 it	 has	 been	 an	 increase	 in	 B220IgE	 and	 B220IgG1	
cytokine	profiles	in	treatment	group	induced	Ovalbumin	on	EEDA	0.00;	0.17;	2.01;	10.04	
g/kg;	Anti	Histamin	Drugs	and	Diosgenin	groups	compared	with	the	control	group	in	the	
sensitization	phase.	The	highest	B220IgE	and	B220IgG1	cytokine	profile			EEDA	10.on04	
g/kg	 group	 and	 	 the	 lowest	 B220IgE	 and	 B220IgG1	 cytokine	 profile	 is	 in	 the	 control	
group	as	shown	in	Figure	2(a).	
The	 results	 are	 consistent	 with	 Barwig	 et	 al.	 (2010),	 Aguilar‐Pimentel	 et	 al.	
(2010)	and	Lee	et	al.	(2013)	that	intraperitoneal	injection	of	Ovalbumin	with	low	doses	
as	 an	 antigen	 together	 with	 Aluminum	 Hydroxide	 as	 adjuvant	 result	 in	 increased	
formation	of	IgE	antibodies	with	high	levels.	The	results	of	this	study	demonstrate	that	
Ovalbumin	 as	 allergens	 managed	 to	 create	 mice	 model	 of	 allergic	 proven	 by	
administering	 Ovalbumin	 can	 increase	 levels	 of	 IgE	 and	 IgG1	 on	 BALB/c	 mice	 on	
sensitivity	phase	because	one	of	the	clinical	symptoms	of	allergy	are	increased	levels	of	
IgE	and	IgG1	(Dourado	et	al.,	2010,	Makiyah	et	al.,	2014).	
Ovalbumin	 in	 this	 study	 can	 stimulate	 allergic	 reactions.	 IgE	 is	 a	 cytokine	 that	
was	very	crucial	in	the	development	of	allergic	reactions	(Li‐Weber	and	Krammer,	2003;	
Cookson,	2004;	Diding	et	al.,	2008).	Haghighi	et	al.	(2006)	showed	that	administration	of	
oral	Ovalbumin	 in	mice	were	 able	 to	 induce	 the	production	of	Th2	 cytokines	 and	 IgE,	
which	it	will	result	in	an	immune	response	to	the	allergic‐inflammatory.	
	
 	
Figure	 2Comparison	 of	 relative	 number	 of	 cells	 of	 mice	 expressing	 B220IgE	 and	 B220IgG1	 and	 	 (b)	 CD4CD25	 and	
CD4CD25FoxP3	 on	 the	 sensitivity	 phase.	 Description:	 a	 bar	 chart	 followed	 by	 the	 same	 letters	 between	 group	means	
there	is	no	significant	difference	(p>	0.05).	
	
There	 are	 significant	 difference	 on	 B220IgE	 and	 B220IgG1	 (p	 <0.05)	 cytokine	
profile	 in	 sensitivity	 phase	 and	 Tukey's	 test	 showed	 there	 are	 significant	 difference	
B220IgE	cytokine	profile	between	EEDA	dose	10,04	g/kg	with	the	Control	group.	EEDA	
dose	 of	 0.00;	 0.17;	 2.01	 g/kg,	 Anti	 Histamine	 Drugs	 and	 Diosgenin	 while	 among	 the	
Control	 group,	 EEDA	 dose	 of	 0.00;	 0.17	 g/kg,	 Anti	 Histamine	 Drug	 and	 Diosgenin	
showed	there	are	no	significant	difference.	Between	EEDA	dose	of	0.00;	0.17;	2.01	g/kg,	
Anti	Histamine	Drug	and	Diosgenin	groups	showed	no	significant	difference.	Tukey	test	
results	 showed	 significantly	 different	 between	 groups	 B220IgG1	 cytokine	 profile	 of	
EEDA	dose	of	 10.04	g/kg	with	 the	Control	 group.	EEDA	dose	of	 0.00;	 0.17;	 2.01	 g/kg,	
Anti	Histamine	Drug	and	Diosgenin	while	among	the	Control	group,	EEDA	dose	of	0.00;	
0.17;	 2.01	 g/kg,	 Anti	 Histamine	 Drug	 and	 Diosgenin	 showed	 there	 are	 no	 significant	
difference.	
CD4+CD25+	cells	 is	 thought	as	conventional	cells	 that	express	 the	CD25	surface	
mole‐cules	 and	 regulatory	 T	 cells	 that	 will	 surely	 increase	 with	 the	 entry	 of	 foreign	
substances	are	inserted	into	the	body.	CD25	surface	molecules	known	also	as	the	IL‐2α	
receptor,	which	may	be	expressed	by	conventional	cells	other	than	CD4+	T	cells	(Lee	et	
2a	 2b	
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al.,	2006).	CD4CD25	Treg	cells	were	identified	by	expression	of	double‐positive	CD4	and	
CD25	markers	specific	membrane.		
This	 study	 showed	 that	 on	 the	 sensitivity	 phase	 already	 increased	 CD4CD25	
cytokine	profile	in	the	EEDA	dose	of	2,01;	10.07	g/kg	and	Anti	Histamine	Drug	group,	as	
also	 been	 has	 an	 increase	 in	 transcription	 factor	 CD4CD25FoxP3	 profile	 in	 the	 EEDA	
doses	of	2.01	and	10.04	g/kg	group	as	shown	in	Figure	3.	CD4CD25	cytokine	profile	and	
transcription	 factors	 CD4CD25FoxP3	 on	 the	 sensitivity	 phase	 showed	 no	 significantly	
difference	(p>	0.05).	
Treg	cells	play	an	important	role	in	immunological	disorder	underlying	allergic	
disease	 (Wu	et	al.,	2007).	Treatment	of	asthma	allergic	diseases	 latest	also	 focused	on	
increasing	 the	 role	 of	 T	 reg	 cells	 to	 protect	 against	 severity	 of	 asthma	 (Nouri‐Aria	 &	
Durham,	2008).	Some	studies	showed	the	occurrence	of	a	significant	reduction	of	Treg	
cells	 	 CD4+CD25+Foxp3	 in	 perifer	 blood	 and	 bronchoalveolar	 lavage	 fluid	 of	 patients	
with	 asthma	 (Ryanna	 et	 al.,	 2009).	 Some	 therapies	 in	 allergic	 disease	 is	 known	 to	
increase	Treg	cells	(Nouri‐Aria	&	Durham,	2008).	Treg	cells	has	been	widely	utilized	as	
an	experimental	model	for	treating	various	diseases	including	allergic	diseases	(Kearley	
et	al.,	2008).	Some	research	has	also	shown	the	role	of	FoxP3	and	CD4CD25	Treg	cells	in	
allergic	disease	(Stock	et	al.,	2006).	
Susanti	 et	 al.	 2013	 research	 on	 children	 with	 asthma	 given	 a	 combination	 of	
adjuvant	and	Nigella	sativa	increase	the	percentage	of	CD4+CD25+Foxp3+	Treg.	Lopes	et	
al.	 (2006)	 research	 proved	 that	 intracellular	 Foxp3	 protein	 delivery	 inhibits	 the	
activation	 of	 T	 cells	 after	 stimulation	 of	 the	 T	 cell	 receptor	 (TCR)	 and	 the	 resulting	
suppressor	function	of	T	cells	CD4+CD25‐.	Many	recent	studies	have	examined	the	role	of	
Foxp3	 Treg	 cells	 and	 CD4+CD25+	 in	 allergic	 asthma	 and	 atopic	 patients	 (Stock	 et	 al.,	
2006).	 Peripheral	 blood	 mononuclear	 cells	 from	 patients	 with	 allergic	 rhinitis	 and	
asthma	had	fewer	lymphocytes	expression	of	Foxp3+	and	Foxp3	mRNA	was	significantly	
decreased	(Hartl	et	al.	2007,	Lee	et	al.,	2007).	Treg	cells	from	atopic	patients	have	less	
suppressor	activity	compared	with	Treg	cells	from	non‐atopic	group	(Ling	et	al.,	2004),	
suggesting	 that	 Treg	 Foxp3	 and	 has	 an	 important	 role	 in	 regulating	 the	 immune	
response	in	humans	hypersensitive.	Therefore,	Foxp3	is	a	very	important	target	for	the	
development	of	immunosuppressive	agents	for	both	autoimmune	diseases	and	allergies.	
Despite	 the	 importance	 of	 Foxp3	 in	 imunotoleransi	 has	 been	 studied	 extensively,	 the	
clinical	use	of	gene	transfer	of	Treg	or	Foxp3	for	this	disease	is	still	 limited	because	of	
the	difficulty	of	isolating	the	T	reg	cells	human,	transfection	efficiencies	are	low,	and	the	
high	risk	gene	viral‐mediated	delivery	(Choi	et	al.,	2010	).	
Treg	 cells	 eject	 function	 of	 its	 imunoregulatory	 through	 various	 mechanisms,	
among	 others,	 require	 CTLA‐4,	 turn	 off	 the	 antigen	 presenting	 cell	 or	 T	 lymphocytes	
directly,	 using	 IL‐2	 cytokine,	 production	 immunosuppression	 cytokine	 such	 as	 IL‐10,	
TGF‐beta,	IL‐35	and	galectin‐1	(Vignali	et	al.,	2008).	
Treg	 cells	 secrete	 IL‐10	 and	 TGF‐β	 in	 bulk	 (Shevach,	 2009).	 IL‐10	 is	 a	
antiinflammatory	 cytokine	 produced	 Treg	 cells	 that	 control	 the	 peripheral	 immune	
response	(Hawrylowicz,	2005)	and	plays	a	role	in	protection	against	allergic	disease	on	
individuals	with	mutations	 in	 FoxP3	 (transcription	 factor	 Treg	 cells)	 in	 patients	 with	
food	 allergy	 (Hawrylowicz,	 2005).	 Immu‐notherapy	 to	 treat	 allergies	 have	 also	 been	
shown	 to	 increase	 levels	 of	 IL‐10,	which	works	 by	 inhibiting	 the	 activity	 of	 Th2	 cells	
(Akdis	 et	 al.,	 1998).	 Kearley	 et	 al.	 (2005)	 found	 a	 decrease	 in	 the	 production	 of	 Th2	
cytokines	 in	mice	 sensitized	with	Ovalbumin	when	granting	Treg	 cells	 purified	before	
exposure	to	antigen;	they	found	that	the	production	of	IL‐10	is	not	limited	to	Treg	cells.		
The	result	indicates	that	the	sensitivity	phase	increased	cytokine	profile	CD4IL‐
10	 in	 the	 treatment	 group,	 namely	 Ovalbumin	 induced	 dose	 group	 EEDA	 0.00;	 0,17;	
2,01;	10.07	g/kg,	treatment	with	Anti	Histamine	Drugs	and	Diosgenin	treatment,	as	well	
as	an	increase	in	CD8IL‐10	cytokine	profiles	in	the	treatment	group,	namely	Ovalbumin	
induced	 dose	 group	 EEDA	 0.00;	 0,17;	 2,01;	 10.07	 g/kg	 and	 treatment	 with	 Anti	
Histamine	Drug	as	shown	in	Figure	2(b).	
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CD4IL‐10	 and	 CD8IL‐10	 cytokine	 profile	 with	 one	way	 Anova	 test	 showed	 no	
significant	difference	on	CD4IL‐10	cytokine	profile	(p>0.05)	and	significantly	difference	
on	 CD8IL‐10	 cytokine	 profile	 (p<0,05).	 Tukey	 test	 results	 showed	 no	 significant	
difference	 CD8IL‐10	 cytokine	 profiles	 between	 treatment	 groups	 EEDA	 dose	 of	 2.01	
g/kg	 with	 Control,	 EEDA	 dose	 of	 0.00;	 0.17;	 10.04	 g/kg,	 Anti	 Histamine	 Drug	 and	
Diosgenin	treatment.	There	was	no	significant	difference	between	Control	groups,	EEDA	
dose	0.0	g/kg,	Anti	Histamine	Drug	and	Diosgenin	treatment.	There	was	no	significant	
difference	between	the	Control	groups	with	the	EEDA	dose	of	0.00;	10.07	g/kg	and	Anti	
Histamine	Drug	treatment,	there	was	no	significant	difference	between	EEDA	0.17	g/kg	
and	10.04	g/kg	groups.	
This	 study	 indicate	 that	 	 on	 the	 sensitivity	phase	 increased	CD4IL‐10	 cytokine	
profile	 in	 the	 treatment	group	 induced	with	Ovalbumin	namely	EEDA	dose	0.00;	0,17;	
2,01;	10.07	g/kg,	Anti	Histamine	Drug	treatment	and	Diosgenin	treatment,	as	well	as	an	
increase	 in	 CD8IL‐10	 cytokine	 profiles	 in	 the	 treatment	 group	 induced	 Ovalbumin	
namely	EEDA	dose	0.00;	0,17;	2,01;	10.07	g/kg	and	Anti	Histamine	Drug	 treatment	as	
shown	in	Figure	3(a).	
CD4IL‐10	 and	 CD8IL‐10	 cytokine	 profile	 in	 sensitivity	 phase	 showed	 no	 significant	
difference	 in	 CD4IL‐10	 cytokine	 profiles	 (p:	 0.061)	 and	 significantly	 difference	 in	
cytokine	 profiles	 CD8IL‐10	 (p:	 0.00).	 Tukey	 test	 showed	 significantly	 difference	 	 on	
CD8IL‐10	 cytokine	 profiles	 between	 EEDA	 dose	 of	 2.01	 g/kg	 treatment	 groups	 with	
Control,	 EEDA	 dose	 0.00;	 0.17;	 10.04	 g/kg,	 Anti	 Histamine	 Drug	 treatment	 and	
Diosgenin	treatment.	There	is	no	significant	difference	between	Control,	EEDA	dose	0,00	
g/kg,	Anti	Histamine	Drug	treatment	and	Diosgenin	treatment	and	there	is	no	significant	
difference	between	the	Control,	EEDA	dose	0,00;	10,	07	g/kg	and	Anti	Histamine	Drug	
treatment,	 no	 significant	 difference	 between	 groups	 EEDA	 dose	 0.17	 g/kg	 and	 EEDA	
dose10.04	g/kg.	
	
	
 
Figure	3.	(a)	Comparison	of	the	relative	number	of	cells	of	mice	expressing	CD4IL‐10	and	CD8IL‐10	 	and	(b)	CD4TGFβ	
and	CD8TGFβ	on	the	sensitivity	phase	after	given	the	ethanol	extract	tubers	of	Dioscorea	alata	L.	(EEDA).	Description:	a	
bar	chart	followed	by	the	same	letters	between	group	means	there	is	no	significant	difference	(p>	0.05).	
	
The	 results	 of	 this	 study	 showed	 that	 the	 CD8TGFβ	 and	 	 CD4TGFβ	 cytokine	
profile	in	sensitivity	phase	increased	in	the	treatment	group	namely	EEDA	dose	of	0,17;	
2,01;	10.07	g/kg,	Anti	Histamine	Drug	treatment	and	Diosgenin	treatment.	
There	is	significantly	differences	in	CD4TGFβ	cytokine	profiles	(p<0.05)	and	no	
significant	 differences	 in	 CD8TGFβ	 cytokine	 profiles	 (p>0.05)	 in	 the	 sensitivity	 phase.	
Tukey	 test	 showed	 there	 is	 significantly	 difference	 in	 CD4TGFβ	 cytokine	 profiles	
between	treatment	groups	EEDA	dose	of	0.17	g/kg	with	Control	group,	EEDA	dose	0,00;	
2.01;	10.04	g/kg,	Anti	Histamine	Drug	treatment	and	Diosgenin	treatment.	There	is	no	
significant	difference	between	Control	 groups,	EEDA	dose	0,00;	2.01;	10.04	g/kg,	Anti	
Histamine	Drug	and	Diosgenin	treatment	as	shown	in	Figure	3(b).	
3a 3b	
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Susceptibility	to	allergic	diseases	can	not	only	be	explained	with	a	single	through	
the	impaired	balance	between	Th1	and	Th2	responses.	Currently	the	immunoregulatory	
role	of	Treg	cells	has	been	known	to	suppress	the	adaptive	immune	response	mediated	
by	Th1	and	Th2	(Herrick	&	Bottomly,	2003;	van	Oosterhout	&	Bloksma,	2005).	
To	 develop	 immunosuppressive	 agents	 for	 treating	 autoimmune	 diseases	 or	
allergies,	 the	 regulation	 of	 T	 cell	 activation	 and	 function	 of	 Treg	 cells	 is	 an	 important	
target.	Foxp3	has	an	 important	 role	not	only	as	a	key	molecule	 in	 the	development	of	
regulatory	 T	 cells,	 but	 also	 as	 an	 inhibitor	 of	 T	 cell	 activation	 and	 repressor	 of	
transcription	 factors	 (Wan	 and	 Flavell,	 2007;	 Campbell	 &	 Ziegler,	 2007;	 Lopes	 et	 al.,	
2006).	
This	study	showed	 that	on	 the	 sensitivity	phase,	giving	EEDA	dose	2.01;	10.04	
g/kg	and	Anti	Histamin	Drug	increase	CD4CD25	cytokine	profile	and	giving	EEDA	2.01;	
10.04	g/kg	increase	transcription	factors	CD4CD25FoxP3,	giving	EEDA	0.17;	2.01;	10.04	
g	 /	 kg;	 Anti	 Histamin	 Drug	 and	 Diosgenin	 increase	 cytokine	 profile	 CD4IL‐10,	 giving	
EEDA	0.17;	2.01;	10.04	g/kg	and	Anti	Histamin	Drug	increase	cytokine	profile	CD8IL‐10,	
giving	EEDA	0.17;	2.01;	10.04	g/kg,	Anti	Histamin	Drug	and	Diosgenin	increase	CD4TGF‐
β	and	CD8TGF	‐β	cytokine	profile.	
The	ethanol	extract	of	Dioscorea	alata	L.	with	the	active	compounds	contained	it,	
one	 of	 which	 is	 a	 saponin	 steroids	 are	 useful	 as	 allergenic	 agent	 able	 to	 activate	
regulatory	 T	 cells	 so	 that	 the	 sensitization	 phase	 EEDA	 2.01	 and	 10.04	 g/kg	 increase	
CD4CD25	cytokine	profile	and	transcription	factors	CD4CD25FoxP3.	BALB/c	mice	which	
only	 induced	 Ovalbumin	 namely	 the	 EEDA	 0,00	 g/kg	 decreased	 the	 percentage	 of	
transcription	 factors	 CD4CD25FoxP3	 on	 the	 sensitization	 phase.	 BALB/c	 mice	 which	
induced	Ovalbumin	and	 treated	EEDA	0.17;	2.01;	 10.04	 g/kg,	Anti	Histamin	Drug	 and	
Diosgenin	are	increase	in	the	percentage	of	transcription	factors	CD4CD25FoxP3	on	the	
sensitization	phase.		
Giving	 EEDA	 has	 no	 significantly	 effect	 on	 CD4CD25	 cytokine	 profiles	 and	 the	
percentage	 of	 CD4CD25FoxP3	 transcription	 factors	 in	 the	 sensitization	 phase.	 This	
shows	 that	 the	 possibility	 of	 increasing	 the	 activity	 of	 T	 reg	 cells	 and	 transcription	
factors	 CD4CD25FoxP3	 triggered	 by	 other	 factors	 including	 through	 the	 profiles	 of	
cytokine	produced	by	T	reg	cells:	CD4IL‐10,	CD8IL‐10,	CD4TGF‐β,	CD8TGF‐β.	The	results	
of	 this	 study	according	 to	Huang	et	 al.	 (2009,	 2010)	which	 showed	an	 increase	 in	 the	
number	of	cells	of	IL‐10+FoxP3+	allergic	of	mice	treated	Diosgenin.	
 
4. Conclusion	
 
Ethanol	 extract	 tubers	 of	 Dioscorea	 alata	 L	 (EEDA)	 does	 not	 trigger	 Treg	
(CD4CD25)	and	 the	 transcription	 factor	FoxP3	 (CD4CD25FoxP3)	and	cytokine	profiles	
produced	 by	 Treg	 cells	 namely	 CD4IL‐10,	 CD8IL‐10,	 CD4TGF‐β	 and	 CD8TGF	 ‐β	 in	 the	
sensitivity	phase.	
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